Better Health
Through
Best Evidence
WHAT
ACTA promotes effective and cost-effective healthcare through clinical trial networks and clinical quality registries that generate evidence to support decisions made by health practitioners, policy-makers and consumers.
HOW
ACTA connects clinical researchers with governments, policy makers and consumers on issues that impact the conduct of investigator-initiated clinical trials across the Australian healthcare system.
WHY
ACTA’s activities help expand the capacity, capability, efficiency and effectiveness of clinical trial networks, clinical coordinating centres and clinical quality registries.
Featured Stories
-
Nominations open for ACTA Trial of the Year Awards
If your network or group published the primary results of a high-impact trial in 2019 (electronically or in print), we encourage you to nominate the trial for the ACTA Trial of the Year Award 2020.
-
COVID-19
We’ve created this area for COVID-19 information relevant to clinical trials. In line with the national guidance and emphasis on the safety and well-being of patients, research participants and their families, and health care professionals, researchers and other staff involved in patient care and research, ACTA strongly supports the continuation of investigator-led trials, where it is safe to do so, and with due consideration to any protocol amendments appropriate for the current COVID-19 pandemic.
-
Activities critical to success and growth of Clinical Trials Networks: Sector consultation
Senior Clinical Trial Networks members and Executive Officers identified key activities critical to the success and sustainability of CTN, and to identify unmet needs.
